dijous, 6 de novembre del 2014

The silver lining for healthcare in U.S. inversion rules




Instead of quashing mergers and acquisitions altogether, the U.S. Treasury Dept.'s proposal on tax inversions may pull dealmaking onshore.






(Reuters) - Investors and bankers have been lamenting the potential death of large cross-border healthcare mergers since the U.S. Treasury Dept. announced in late September that it would curtail the tax breaks from international deals designed to give U.S. companies a legal home in a low-tax country.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1At77Wj

Cap comentari:

Publica un comentari a l'entrada